Published: 24 September 2015
Author(s): Xiang Li, Min Wang, Guiyang Liu, Jianli Ma, Chuntong Li
Section: Original Article

A large body of evidences suggested that macrolide therapy could improve the survival of patients with various infections. While in the same time, macrolides are known to increase fatal arrhythmogenic risks and cause cardiac death. To assess the risks and benefits of macrolide therapy, we systematically reviewed all studies of macrolide use, cardiac death and mortality among patients with various infections.


Stay informed on our latest news!